Real-time PCR for pharmacodynamic studies of Chlamydia trachomatis

被引:10
作者
Storm, M
Gustafsson, I
Herrmann, B
Engstrand, L
机构
[1] Swedish Inst Infect Dis Control, Dept Clin Bacteriol, SE-17182 Solna, Sweden
[2] Uppsala Univ, Dept Med Sci Clin Bacteriol, Uppsala, Sweden
关键词
real-time PCR; resistance; persistence; C; trachomatis; pharmacodynamics; antibiotics; susceptibility testing; MIC;
D O I
10.1016/j.mimet.2004.12.015
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Pharmacodynamic knowledge about Chlamydia trachomatis exposed to antibiotics is hampered due to methodological limitations. We have developed a quantitative real-time PCR method (qRT-PCR) for determination of viable C. trachomatis. The method measures specific RNA transcripts of omp2 (omcB) as an expression of viable C. trachomatis. Two clinical isolates (one strain derived from a patient with recurrent symptoms despite doxycycline treatment) were cultured in McCoy cells and exposed to doxycycline at concentrations of 0.0078-64 mg/L. MIC values were evaluated microscopically by immunofluorescence (IF) and by qRT-PCR performed on cDNA prepared from the total RNA. The MIC for two C. trachomatis strains were determined to 0.016 and 0.031 mg/L by both qRT-PCR and IF. The qRT-PCR assay enabled MIC determinations without subjective evaluation, which is a problem when visually evaluating inclusions. The presented qRT-PCR is a suitable method for MIC determination of C. trachomatis. It has the advantage of giving quantitative measurements of chlamydial RNA levels and the method is useful in pharmacodynamic studies of C. trachomatis. (c) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:361 / 367
页数:7
相关论文
共 15 条
  • [1] Chlamydia trachomatis infection:: incidence, health costs and prospects for vaccine development
    Beagley, KW
    Timms, P
    [J]. JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 2000, 48 (01) : 47 - 68
  • [2] Beatty Wandy L., 1994, Trends in Microbiology, V2, P94, DOI 10.1016/0966-842X(94)90542-8
  • [3] Quantification of mRNA using real-time reverse transcription PCR (RT-PCR): trends and problems
    Bustin, SA
    [J]. JOURNAL OF MOLECULAR ENDOCRINOLOGY, 2002, 29 (01) : 23 - 39
  • [4] Antimicrobial susceptibility testing of Chlamydia trachomatis using a reverse transcriptase PCR-based method
    Cross, NA
    Kellock, DJ
    Kinghorn, GR
    Taraktchoglou, M
    Bataki, E
    Oxley, KM
    Hawkey, PM
    Eley, A
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (09) : 2311 - 2313
  • [5] Evidence for long-term cervical persistence of Chlamydia trachomatis by omp1 genotyping
    Dean, D
    Suchland, RJ
    Stamm, WE
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2000, 182 (03) : 909 - 916
  • [6] Sequencing of gyrase and topoisomerase IV quinolone-resistance-determining regions of Chlamydia trachomatis and characterization of quinolone-resistant mutants obtained in vitro
    Dessus-Babus, S
    Bébéar, CM
    Charron, A
    Bébéar, C
    de Barbeyrac, B
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (10) : 2474 - 2481
  • [7] Effects of azithromycin and rifampin on Chlamydia trachomatis infection in vitro
    Dreses-Werringloer, U
    Padubrin, I
    Zeidler, H
    Köhler, L
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (11) : 3001 - 3008
  • [8] Persistence of Chlamydia trachomatis is induced by ciprofloxacin and ofloxacin in vitro
    Dreses-Werringloer, U
    Padubrin, I
    Jürgens-Saathoff, B
    Hudson, AP
    Zeidler, H
    Köhler, L
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (12) : 3288 - 3297
  • [9] In vitro pharmacodynamics of the new ketolides HMR 3004 and HMR 3647 (telithromycin) against Chlamydia pneumoniae
    Gustafsson, I
    Hjelm, E
    Cars, O
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (07) : 1846 - 1849
  • [10] Chlamydial persistence: beyond the biphasic paradigm
    Hogan, RJ
    Mathews, SA
    Mukhopadhyay, S
    Summersgill, JT
    Timms, P
    [J]. INFECTION AND IMMUNITY, 2004, 72 (04) : 1843 - 1855